Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.
 

Pfizer and AstraZeneca a Marriage Not to Be – Yet?

Contributor: Stephen Archer
Posted: 8/19/2014

Pfizer and AstraZeneca a Marriage Not to Be – Yet? - Stephen Archer

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success in delivering the anticipated benefits is not good. Full Article »


Events related to this topic:

Preventing Type 2 Diabetes in the MENA Region

Contributor: Andrea Charles
Posted: 12/20/2011


Preventing Type 2 Diabetes in the MENA Region - Andrea Charles

Diabetes is a global threat. Researchers estimate that 26.6 million people in the Middle East and North Africa currently have diabetes. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. In this interview diabetes expert Professor Peter Schwarz, talks about the alarming growth of diabetes in the MENA region and strategies for prevention and management. Full Podcast »


Events related to this topic:

Austerity-Driven Policy Dictates a Challenging Environment for Pharma

Contributor: Dr Steven Bradshaw & Eirini Anastasaki
Posted: 4/20/2015


Austerity-Driven Policy Dictates a Challenging Environment for Pharma - Dr Steven Bradshaw & Eirini Anastasaki

The austerity measures put in place as part of the 'Troika' bailout after Greece's mid-2000s financial crisis included the aim to substantially reduce national drugs spend. With the country already having one of the lowest drug prices in Europe (calculated as the average of the three lowest-price countries), additional budgetary pressure has increased the challenges for pharmaceutical companies in Greece. Full Column »


Events related to this topic:

The Top 10 Asthma Drugs: Sales & Predictions

The global market for asthma drugs is set to hit $18 billion by 2021, according to new research from pharmaceutical analyst firm, Datamonitor Healthcare. We take a closer look at the current top 10 asthma drugs and predictions for this lucrative market. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community